Nobutaka Hattori
- Neurology top 0.01%
- Parkinson's Disease Mechanisms and Treatments 471
- Neurological disorders and treatments 177
- Neurological diseases and metabolism 88
- Botulinum Toxin and Related Neurological Disorders 56
- Neurology top 0.02%
- Parkinson's Disease Mechanisms and Treatments 471
- Neurological disorders and treatments 177
- Neurological diseases and metabolism 88
- Botulinum Toxin and Related Neurological Disorders 56
- Cellular and Molecular Neuroscience top 0.05%
- Nuclear Receptors and Signaling 88
- Genetic Neurodegenerative Diseases 63
- Physiology top 0.1%
- Alzheimer's disease research and treatments 60
- Cell Biology top 0.1%
-
- Autophagy in Disease and Therapy 62
- Co-authors
- Yoshikuni MizunoShuichi AsakawaSatoshi MinoshimaNobuyoshi ShimizuHiroto MatsumineShigeto SatoYasuhiro YamamuraTohru Kitada
- Partner nations
- JapanUnited StatesItaly
In The Last Decade
Nobutaka Hattori
1.1k papers receiving 41.9k citations
Hit Papers
Peers
Comparison fields: 5 of 195
- Neurology 19.7k
- Neurology 5.8k
- Cellular and Molecular Neuroscience 10.6k
- Physiology 7.5k
- Cell Biology 4.2k
Countries citing papers authored by Nobutaka Hattori
This map shows the geographic impact of Nobutaka Hattori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobutaka Hattori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobutaka Hattori more than expected).
Fields of papers citing papers by Nobutaka Hattori
This network shows the impact of papers produced by Nobutaka Hattori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobutaka Hattori. The network helps show where Nobutaka Hattori may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nobutaka Hattori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 7 | |
| 11 | 2021 | 33 | |
| 12 | 2021 | 12 | |
| 13 | 2019 | 48 | |
| 14 | 2018 | 38 | |
| 15 | 2017 | 86 | |
| 16 | 2012 | 65 | |
| 17 | Homozygous PARK7 Mutation in Parkinson’s Disease: Case Report of Two Brothers | 2008 | 2 |
| 18 | [A 62-year-old woman with early-onset Parkinson's disease associated with the PINKi gene deletion]. | 2006 | 10 |
| 19 | 2005 | 23 | |
| 20 | 1994 | 179 |
About Nobutaka Hattori
Nobutaka Hattori is a scholar working on Neurology, Neurology and Cellular and Molecular Neuroscience, having authored 1.1k papers that have together received 42.6k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (471 papers), Neurological disorders and treatments (177 papers), Neurological diseases and metabolism (88 papers), Nuclear Receptors and Signaling (88 papers), Genetic Neurodegenerative Diseases (63 papers), Autophagy in Disease and Therapy (62 papers), Alzheimer's disease research and treatments (60 papers) and Botulinum Toxin and Related Neurological Disorders (56 papers). The work is most often cited by research in Neurology (19.7k citations), Neurology (5.8k citations) and Cellular and Molecular Neuroscience (10.6k citations). Nobutaka Hattori has collaborated with scholars based in Japan, United States and Italy. Frequent co-authors include Yoshikuni Mizuno, Shuichi Asakawa, Satoshi Minoshima, Nobuyoshi Shimizu, Hiroto Matsumine, Shigeto Sato, Yasuhiro Yamamura, Tohru Kitada, Masayuki Yokochi and Keiji Tanaka. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.